
Bioorganic and Medicinal Chemistry Letters p. 3123 - 3126 (1999)
Update date:2022-08-04
Topics:
Yoshida, Yoshiki
Matsuda, Keiji
Sasaki, Hiroshi
Matsumoto, Yoshimi
Matsumoto, Satoru
Takasugi, Hisashi
The synthesis and anti-Helicobacter pylori activity of a novel cephem derivative FR182024 (1) are described. FR182024 having a (5-methyl-1,3,4-thiadiazol-2-yl)-thio moiety at the 3-position and a phenylacetamido at the 7-position was found to have extremely potent in vitro anti-H.pylori activity, superior therapeutic efficacy to AMPC and CAM, and low potential for causing diarrhea.
View MoreNanjing Chemipioneer Pharma&Tech Co.,Ltd
website:http://www.chemipioneer.com.cn
Contact:+86-25-52685700
Address:Room 305,A Block,Biological-Medicine Building,Business Start-up Center,Xin-ke 1st Road, High-tech development zone,Nanjing city,Jiangsu Province, China
ChangZhou Mascotchem. Co.,Ltd.
website:http://www.mascotchem.com
Contact:86-519-85010339
Address:B-802,XingBei Building,391#,Tongjiang Middle Road New District,Changzhou,JS,China
Shifang Taifeng New Flame Retardant Co., Ltd
Contact:02884721008
Address:tingjiang industrial park, hefeng town
Contact:+86-515-88356562
Address:No.2, West Daqing Road, Yancheng, Jiangsu, China
website:http://www.vanzpharm.com/en/index.html
Contact:86-27-84492310
Address:FANHU INDUSTRY PARK
Doi:10.1016/0031-9422(96)00242-7
(1996)Doi:10.1039/b912325c
(2009)Doi:10.1016/0020-1650(68)80164-3
(1968)Doi:10.1016/S0022-328X(96)87021-5
(1996)Doi:10.1007/BF00702025
()Doi:10.1039/dt9960002541
(1996)